Concourse Financial Group Securities, Inc. Rani Therapeutics Holdings, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
17 transactions
Others Institutions Holding RANI
# of Institutions
41Shares Held
6.38MCall Options Held
29.4KPut Options Held
0-
Armistice Capital, LLC New York, NY3.15MShares$6.05 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA885KShares$1.7 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$947,6810.48% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$581,2660.02% of portfolio
-
Geode Capital Management, LLC Boston, MA191KShares$365,8690.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $47M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...